Eastman Chemical Co (EMN) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Eastman Chemical Co (EMN) stock forecast summary
Our AI ranks Eastman Chemical Co outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Eastman Chemical Co is a mid-cap company with a market capitalization of $7.21B. It ranks number 3 by market capitalization among the 9 Plastic Materials, Synth Resins & Nonvulcan Elastomers issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for EMN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, EMN included.
Follow EMN freeEMN price chart and AI forecast
How EMN ranks among 5379 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Eastman Chemical Co (EMN) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Plastic Materials, Synth Resins & Nonvulcan Elastomers peers listed below that report each metric.
Valuation & Market
| Metric | EMN | Rank |
|---|---|---|
| Market Cap | $7.21B | 3/9 |
| P/E Ratio | 16.30x | – |
| P/B Ratio | 1.18x | 5/8 |
| Dividend Yield | 5.30% | 1/6 |
| EPS | $2.92 | – |
| Book Value/Share | $53.30 | – |
| Revenue/Share | $77.51 | – |
| FCF/Share | $4.71 | – |
Profitability & Margins
| Metric | EMN | Rank |
|---|---|---|
| ROE | 7.2% | – |
| ROA | 2.9% | 2/6 |
| Gross Margin | 19.9% | 5/8 |
| Net Margin | 5.0% | 2/6 |
| EBT Margin | 6.1% | 3/10 |
| Tax Rate | 17.7% | – |
Financial Health
| Metric | EMN | Rank |
|---|---|---|
| Current Ratio | 1.50x | 7/10 |
| Quick Ratio | 0.76x | 8/10 |
| D/E Ratio | 1.52x | 2/8 |
| Financial Leverage | 2.53x | 2/8 |
| Interest Coverage | -16.5x | 7/7 |
| Working Capital | $1.42B | 3/10 |
Cash Flow
| Metric | EMN | Rank |
|---|---|---|
| Operating Cash Flow | $991M | 3/9 |
| Free Cash Flow | $539M | 3/9 |
| Capital Spending | -$452M | 8/9 |
| OCF Growth YoY | -1.1% | 4/7 |
| FCF Growth YoY | 32.8% | 3/6 |
| FCF/Sales | 6.1% | 6/9 |
| CapEx/Sales | 5.1% | 5/9 |
Operational Efficiency
| Metric | EMN | Rank |
|---|---|---|
| Asset Turnover | 0.57x | 5/9 |
| Receivables Turnover | 8.1x | 2/7 |
| Inventory Turnover | 3.4x | 6/8 |
| Fixed Assets Turnover | 1.6x | 4/9 |
| Days Sales Outstanding | 45 days | 6/7 |
| Days Inventory | 108 days | 3/8 |
Income Statement
| Metric | EMN | Rank |
|---|---|---|
| Total Revenue | $8.87B | 1/9 |
| Net Income | $442M | 1/6 |
| R&D Expense | $246M | 1/6 |
| SG&A Expense | $682M | 3/9 |
| Cost of Goods Sold | $7.10B | 1/8 |
Dividend & Shareholder Information
| Metric | EMN | Rank |
|---|---|---|
| Dividends Per Share | $3.34 | – |
| Payout Ratio | 114.4% | 3/6 |
| Shares Outstanding | 114M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $4.25B | 27.6% of assets |
| Cash & Short-term Investments | $691M | 4.5% of assets |
| Accounts Receivable | $1.10B | 7.1% of assets |
| Inventory | $2.10B | 13.6% of assets |
| Total Liabilities | $9.25B | 60.0% of assets |
EMN quarterly financials and insider trading
Eastman Chemical Co (EMN) industry peers
Companies classified under the same SEC industry code as Eastman Chemical Co (Plastic Materials, Synth Resins & Nonvulcan Elastomers): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| EMN Eastman Chemical Co | ▲ | $7.21B |
| DD Dupont De Nemours, Inc. | ▼ | $17.49B |
| ALB Albemarle Corp | ▼ | $11.52B |
| HXL Hexcel Corp /De/ | ▼ | $6.51B |
| AVNT Avient Corp | ▼ | $3.63B |
| ROG Rogers Corp | ▶ | $2.61B |
| PCT Purecycle Technologies, Inc. | ▲ | $691M |
| ASIX Advansix Inc. | ▼ | $449M |
| TSEOQ Trinseo Plc | ▶ | $150K |
| HGYN Hong Yuan Holding Group | ▶ | N/A |
Where EMN sits on the market map
Eastman Chemical Co (EMN) stock news
Loading...
Eastman Chemical Co (EMN) stock forecast FAQ
What is the Eastman Chemical Co (EMN) stock forecast?
Our AI ranks Eastman Chemical Co outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Eastman Chemical Co stock predictions?
A per-ticker accuracy statistic for EMN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Eastman Chemical Co forecasts updated?
Eastman Chemical Co forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Eastman Chemical Co's industry peers?
10 issuers in our coverage, EMN included, share the SEC industry code Plastic Materials, Synth Resins & Nonvulcan Elastomers. The largest are: Dupont De Nemours, Inc. (DD), Albemarle Corp (ALB), Hexcel Corp /De/ (HXL), Avient Corp (AVNT), Rogers Corp (ROG), Purecycle Technologies, Inc. (PCT).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.